Clinical trials
Phase 3 Atherosclerosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
121 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 11 |
| 2004 | 8 |
| 2005 | 5 |
| 2006 | 4 |
| 2007 | 8 |
| 2008 | 4 |
| 2009 | 5 |
| 2010 | 4 |
| 2011 | 4 |
| 2012 | 3 |
| 2013 | 1 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 5 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 8 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 81 |
| Active, not recruiting | 11 |
| Recruiting | 11 |
| Unknown status | 9 |
| Terminated | 8 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 8 |
| Esperion Therapeutics, Inc. | 6 |
| National Heart, Lung, and Blood Institute (NHLBI) | 6 |
| AstraZeneca | 5 |
| Eli Lilly and Company | 4 |
| Organon and Co | 4 |
| Boston Scientific Corporation | 3 |
| GlaxoSmithKline | 3 |
| Institute for Atherosclerosis Research, Russia | 3 |
| Kos Pharmaceuticals | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atherosclerosis | 121 |
| Hypercholesterolemia | 23 |
| Cardiovascular Diseases | 20 |
| Coronary Disease | 12 |
| Peripheral Arterial Disease | 12 |
| Coronary Artery Disease | 11 |
| Myocardial Infarction | 10 |
| Heart Diseases | 9 |
| Hyperlipidemias | 9 |
| Peripheral Vascular Diseases | 9 |
Trials
Showing 76 to 100 of 121. Each trial links to its page on Pharma Observatory.
21 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.